HPGC Renmintongtai Pharmaceutical Corp Financial Flexibility Index
HPGC Renmintongtai Pharmaceutical Corp financial flexibility index. HPGC Renmintongtai Pharmaceutical Corp (600829) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of CN¥-180.70 Million (operating CF CN¥-187.38 Million minus capex CN¥6.68 Million) represents 0% of total liabilities (CN¥4.03 Billion). See free cash flow generation of HPGC Renmintongtai Pharmaceutical Corp to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Financial flexibility index of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. Historical Financial Flexibility Index trend for HPGC Renmintongtai Pharmaceutical Corp across 28 annual periods. Check 600829 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
HPGC Renmintongtai Pharmaceutical Corp Financial Flexibility Index by Year (1998–2025)
HPGC Renmintongtai Pharmaceutical Corp financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for HPGC Renmintongtai Pharmaceutical Corp. For the full cash flow conversion analysis, see 600829 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | CN¥317.13 Million | CN¥299.98 Million | CN¥4.16 Billion | ▲ +164.6% |
| 2024 | 0.03x | CN¥123.48 Million | CN¥115.44 Million | CN¥4.29 Billion | ▼ -62.2% |
| 2023 | 0.08x | CN¥356.47 Million | CN¥332.99 Million | CN¥4.68 Billion | ▲ +11.7% |
| 2022 | 0.07x | CN¥313.75 Million | CN¥307.33 Million | CN¥4.60 Billion | ▲ +240.7% |
| 2021 | -0.05x | CN¥-220.76 Million | CN¥-233.00 Million | CN¥4.55 Billion | ▼ -4192.9% |
| 2020 | 0.00x | CN¥4.75 Million | CN¥-9.22 Million | CN¥4.00 Billion | ▲ +101.1% |
| 2019 | -0.11x | CN¥-403.27 Million | CN¥-411.60 Million | CN¥3.70 Billion | ▼ -182.9% |
| 2018 | 0.13x | CN¥372.19 Million | CN¥366.45 Million | CN¥2.83 Billion | ▲ +190.3% |
| 2017 | 0.05x | CN¥146.17 Million | CN¥139.07 Million | CN¥3.23 Billion | ▲ +108.0% |
| 2016 | 0.02x | CN¥68.82 Million | CN¥46.01 Million | CN¥3.16 Billion | ▼ -83.5% |
| 2015 | 0.13x | CN¥369.57 Million | CN¥333.99 Million | CN¥2.81 Billion | ▼ -63.8% |
| 2014 | 0.36x | CN¥409.64 Million | CN¥392.58 Million | CN¥1.13 Billion | ▲ +518.1% |
| 2013 | -0.09x | CN¥-125.31 Million | CN¥-158.31 Million | CN¥1.44 Billion | ▼ -160.1% |
| 2012 | 0.14x | CN¥252.13 Million | CN¥221.57 Million | CN¥1.75 Billion | ▲ +1751.3% |
| 2011 | -0.01x | CN¥-16.69 Million | CN¥-108.30 Million | CN¥1.91 Billion | ▼ -106.4% |
| 2010 | 0.14x | CN¥217.89 Million | CN¥162.99 Million | CN¥1.58 Billion | ▼ -69.5% |
| 2009 | 0.45x | CN¥541.18 Million | CN¥447.82 Million | CN¥1.20 Billion | ▲ +6465.7% |
| 2008 | 0.01x | CN¥8.72 Million | CN¥-65.93 Million | CN¥1.27 Billion | ▼ -96.2% |
| 2007 | 0.18x | CN¥233.86 Million | CN¥191.10 Million | CN¥1.27 Billion | ▼ -19.3% |
| 2006 | 0.23x | CN¥262.87 Million | CN¥191.13 Million | CN¥1.16 Billion | ▼ -28.1% |
| 2005 | 0.32x | CN¥348.00 Million | CN¥313.04 Million | CN¥1.10 Billion | ▲ +96.2% |
| 2004 | 0.16x | CN¥133.38 Million | CN¥60.69 Million | CN¥828.09 Million | ▼ -68.9% |
| 2003 | 0.52x | CN¥267.11 Million | CN¥71.65 Million | CN¥516.46 Million | ▲ +14.2% |
| 2002 | 0.45x | CN¥182.81 Million | CN¥127.49 Million | CN¥403.72 Million | ▲ +315.0% |
| 2001 | 0.11x | CN¥50.15 Million | CN¥14.79 Million | CN¥459.59 Million | ▼ -52.5% |
| 2000 | 0.23x | CN¥122.94 Million | CN¥61.85 Million | CN¥534.74 Million | ▼ -35.0% |
| 1999 | 0.35x | CN¥101.66 Million | CN¥58.21 Million | CN¥287.56 Million | ▲ +38.9% |
| 1998 | 0.25x | CN¥61.55 Million | CN¥41.00 Million | CN¥241.76 Million | — |